DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021" report to their offering.
This newly published report on the advanced and targeted drug delivery market forecasts the market to grow at a 10.4% CAGR to $319 billion by 2021 from $168 billion today. Supported by over 300 tables and figures, this 382 page report is an extensive industry analysis specifically written for C-Suite, VP and Higher executives within the Pharma and Biotech space.
The advanced and targeted drug delivery market is segmented and analyzed through to 2021 with corresponding CAGR breakdown by:
- Technology
- Geography (Global, USA, Europe, RoW)
- Therapeutic Area (Pulmonary, Ocular drug delivery, Ocular nano-based drug delivery implants, Drug Eluting Stents,
-
Sub-Market Analysis (details below)
The monoclonal antibody market is further broken down and presented as the top selling mAbs by company, class and revenue through to 2021 with corresponding CAGR values. Specific figures are given in relation to Humira, Remicade, Avastin, Rituxan, Soliris, Herceptin, Kadcyla, Perjeta, Lucentis, Xgeva/Prolia, Stelara and Tysarbi.
Key Topics Covered:
1.0 Introduction
2.0 Targeted Drug Delivery: An Overview
3.0 Targeted Drug Delivery and Nanomedicines: An Overview
4.0 Lipid-Based Targeted Drug Delivery Nanosystems
5.0 Polymer-Based Carriers for Targeted Drug Delivery
6.0 Polymeric Micelle/Co-Polymers for Targeted Drug Delivery
7.0 Dendrimer-Based Targeted Drug Delivery
8.0 Inorganic Nanoparticles for Targeted Drug Delivery
9.0 Cell-Based Systems for Targeted Delivery
10.0 Nucleic Acid/Peptide as Drug Carriers
11.0 Targeted Therapies by Indication: An Overview
12.0 Other Targeted Drug Delivery Technologies
13.0 Market Analysis to 2021
14.0 Selected Company Profiles
Companies Mentioned:
- 3M Company
- Abbott Laboratories
- Ablynx NV
- Aciont Inc.
- Acrux
- Agilis Biotherapeutics LLC
- Aileron Therapeutics Inc.
- Alchemia Oncology Pty Ltd.
- Alkermes Pharma Ireland Ltd.
- Allergan Inc.
- Alnylam Pharmaceuticals
- AmpliPhi Biosciences
- Andros Pharmaceuticals Co., Ltd.
- Angiochem Inc.
- Antares Pharma Inc.
- Aposense Ltd.
- Applied Genetic Technologies Corp. (AGTC)
- Aptagen LLC
- Aradigm Corp.
- ArisGen SA
- Armagen Technologies Inc.
- Arrowhead Research Corp.
- Artificial Cell Technologies Inc.
- AsclepiX Therapeutics LLC
- Asklepios BioPharmaceutical Inc.
-
(150+ More)
For more information visit http://www.researchandmarkets.com/research/pdbhkz/advanced_and
